NYSE:EXAM - Examworks Group Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Examworks Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.56 million shsAverage Volume660,679 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ExamWorks Group, Inc is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryHealth Care Services SectorN/A Current SymbolNYSE:EXAM Previous Symbol CUSIP30066A10 CIK1498021 Webhttp://www.examworks.com/ Phone+1-404-9522400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive EXAM News and Ratings via Email Sign-up to receive the latest news and ratings for EXAM and its competitors with MarketBeat's FREE daily newsletter. Examworks Group (NYSE:EXAM) Frequently Asked Questions What is Examworks Group's stock symbol? Examworks Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "EXAM." How were Examworks Group's earnings last quarter? Examworks Group, Inc. (NYSE:EXAM) announced its quarterly earnings results on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. The business services provider earned $226.50 million during the quarter, compared to analyst estimates of $217.47 million. Examworks Group's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.05 EPS. View Examworks Group's Earnings History. Has Examworks Group been receiving favorable news coverage? News coverage about EXAM stock has been trending extremely negative on Tuesday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Examworks Group earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Examworks Group. Who are some of Examworks Group's key competitors? Some companies that are related to Examworks Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). What other stocks do shareholders of Examworks Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Examworks Group investors own include Halozyme Therapeutics (HALO), Ionis Pharmaceuticals (IONS), Nektar Therapeutics (NKTR), Intrexon (XON), Ciena (CIEN), Community Health Systems (CYH), Alnylam Pharmaceuticals (ALNY), Ambarella (AMBA), Anacor Pharmaceuticals (ANAC) and bluebird bio (BLUE). What is Examworks Group's official website? The official website for Examworks Group is http://www.examworks.com/. How can I contact Examworks Group? Examworks Group's mailing address is 3280 Peachtree Rd NE Ste 2625, ATLANTA, GA 30305-2457, United States. The business services provider can be reached via phone at +1-404-9522400. MarketBeat Community Rating for Examworks Group (NYSE EXAM)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 327 (Vote Outperform)Underperform Votes: 240 (Vote Underperform)Total Votes: 567MarketBeat's community ratings are surveys of what our community members think about Examworks Group and other stocks. Vote "Outperform" if you believe EXAM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: Forex
